192 related articles for article (PubMed ID: 32605963)
1. Nuclear Medicine, Molecular Imaging, and Theranostics: The Future Is Bright.
Czernin J; Calais J
J Nucl Med Technol; 2020 Jun; 48(Suppl 1):82S-83S. PubMed ID: 32605963
[No Abstract] [Full Text] [Related]
2. Nuclear medicine in the era of personalised medicine.
Lee ST; Scott AM
Intern Med J; 2018 May; 48(5):497-499. PubMed ID: 29722186
[No Abstract] [Full Text] [Related]
3. Molecular imaging and therapy in nuclear medicine.
Bouziotis P
Curr Top Med Chem; 2012; 12(23):2641. PubMed ID: 23339759
[No Abstract] [Full Text] [Related]
4. SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
Schwarz SW
J Nucl Med; 2017 Jun; 58(6):19N. PubMed ID: 28572297
[No Abstract] [Full Text] [Related]
5. Recent Advances in Quantitative Nuclear Medicine and Molecular Imaging.
Zhou Y; Lu J; Ran C; Zhang J
Contrast Media Mol Imaging; 2018; 2018():3613156. PubMed ID: 30046294
[No Abstract] [Full Text] [Related]
6. Renewed energy for nuclear medicine and molecular imaging.
Pappas V
J Nucl Med; 2011 Aug; 52(8):20N. PubMed ID: 21810588
[No Abstract] [Full Text] [Related]
7. World Molecular Imaging Congress 2015: precision medicine visualized.
Manning HC
Mol Imaging Biol; 2015 Jun; 17(3):295-6. PubMed ID: 25862478
[No Abstract] [Full Text] [Related]
8. Nuclear medicine and anatomic pathology in personalized medicine: a challenging alliance.
Urbano N; Scimeca M; Bonanno E; Schillaci O
Per Med; 2018 Nov; 15(6):457-459. PubMed ID: 30398094
[No Abstract] [Full Text] [Related]
9. Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs.
Czernin J
J Nucl Med; 2019 Aug; 60(8):1037. PubMed ID: 31371618
[No Abstract] [Full Text] [Related]
10. Highlights lecture EANM 2016: "Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine".
Aboagye EO; Kraeber-Bodéré F
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1559-1574. PubMed ID: 28597119
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy.
Broos K; Lecocq Q; Raes G; Devoogdt N; Keyaerts M; Breckpot K
Theranostics; 2018; 8(13):3559-3570. PubMed ID: 30026866
[TBL] [Abstract][Full Text] [Related]
12. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
13. SNMMI 2019 Annual Meeting.
Collingridge D
Lancet Oncol; 2019 Aug; 20(8):1057. PubMed ID: 31257179
[No Abstract] [Full Text] [Related]
14. Examining the nuclear medicine advanced associate: past, present, and future-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist section.
Owen MA; Gilmore CD; Henkin R; Baldwin J; Bires AM; Nelson KP; Wilkinson D; Holbrook S; Hubble W; Mann A; Sobey K; Wintering NA
J Nucl Med Technol; 2014 Sep; 42(3):223-7. PubMed ID: 25125451
[No Abstract] [Full Text] [Related]
15. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
16. Clinical research: the future of the molecular imaging technologist-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist section.
Holbrook S; Baldwin J; Gilmore CD; Henkin R; Hubble W; Kiss C; Bires AM; Mann A; Nelson KP; Owen MA; Sobey K; Stuckey A; Wenzel-Lamb N; Wilkinson D; Wintering NA
J Nucl Med Technol; 2014 Sep; 42(3):228-32. PubMed ID: 25125447
[No Abstract] [Full Text] [Related]
17. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
18. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
19. The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today.
Oprea-Lager DE; MacLennan S; Dierckx R; Fanti S
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1462-1463. PubMed ID: 38280047
[No Abstract] [Full Text] [Related]
20. Planning the future for nuclear medicine and molecular imaging.
King B
J Nucl Med Technol; 2013 Mar; 41(1):7A. PubMed ID: 23586089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
